Sader Helio S, Jones Ronald N, Andrade-Baiocchi Soraya, Biedenbach Douglas J
Laboratório Especial de Microbiologia Clínica, Division of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, Brazil.
Diagn Microbiol Infect Dis. 2002 Nov;44(3):273-80. doi: 10.1016/s0732-8893(02)00469-8.
As part of the Latin American arm of the SENTRY Antimicrobial Surveillance Program, 7,207 bacterial isolates collected consecutively from bloodstream infections (BSI) during the period of January 1997 through December 2000 were analyzed. Ten Latin American laboratories located in six countries participated in the study during each year. Antimicrobial susceptibility testing was performed using the reference NCCLS broth microdilution method. The most frequently isolated species were (n/%): Staphylococcus aureus (1,532/21.3%), Escherichia coli (1,239/17.2%), coagulase-negative Staphylococcus (1,002/13.9%), Klebsiella pneumoniae (664/9.2%), and Pseudomonas aeruginosa (470/6.5%). The prevalence of S. aureus as a cause of BSI increased from 20.5% in 1997 to 23.3% in 2000 (p = 0.011), but oxacillin-resistance rates remained relatively stable during this period (around 30%). Enterococci (216 isolates) showed low rates of resistance to both vancomycin (2.4%) and ampicillin (7.9%) and 72.7% of 289 Streptococcus pneumoniae isolates evaluated were susceptible to penicillin (MIC </=0.06 microg/mL). Resistance rates among Gram-negative bacilli were much higher than those reported in other regions evaluated in the SENTRY Program. The main antimicrobial resistance problems among these pathogens were the high prevalences of ESBL-producing E. coli (6.7%) and K. pneumoniae (47.3%), and carbapenem-resistance among P. aeruginosa (around 12%) and Acinetobacter spp. (around 10%). P. aeruginosa resistance rates to meropenem, piperacillin/tazobactam, amikacin, and ciprofloxacin showed a significant increase during the 4-year period evaluated. Resistance rates varied according to the country for several pathogen-antimicrobial combinations. In summary, resistance to most antimicrobial agents for a number of species implicated in bacteremia, especially among Gram-negative rods, has reached worrisome levels and continues to increase.
作为哨兵抗菌监测计划拉丁美洲部分的工作内容,对1997年1月至2000年12月期间从血流感染(BSI)中连续收集的7207株细菌分离株进行了分析。每年有位于六个国家的十个拉丁美洲实验室参与该研究。采用参考的美国国家临床实验室标准委员会(NCCLS)肉汤微量稀释法进行药敏试验。最常分离出的菌种及数量(百分比)为:金黄色葡萄球菌(1532株/21.3%)、大肠埃希菌(1239株/17.2%)、凝固酶阴性葡萄球菌(1002株/13.9%)、肺炎克雷伯菌(664株/9.2%)和铜绿假单胞菌(470株/6.5%)。金黄色葡萄球菌作为BSI病因的患病率从1997年的20.5%上升至2000年的23.3%(p = 0.011),但在此期间苯唑西林耐药率保持相对稳定(约30%)。肠球菌(216株分离株)对万古霉素(2.4%)和氨苄西林(7.9%)的耐药率较低,在评估的289株肺炎链球菌分离株中,72.7%对青霉素敏感(最低抑菌浓度≤0.06μg/mL)。革兰阴性杆菌的耐药率远高于哨兵计划评估的其他地区报告的耐药率。这些病原体中的主要耐药问题是产超广谱β-内酰胺酶(ESBL)的大肠埃希菌(6.7%)和肺炎克雷伯菌(47.3%)的高患病率,以及铜绿假单胞菌(约12%)和不动杆菌属(约10%)中的碳青霉烯类耐药。在评估的4年期间,铜绿假单胞菌对美罗培南、哌拉西林/他唑巴坦、阿米卡星和环丙沙星的耐药率显著上升。对于几种病原体-抗菌药物组合,耐药率因国家而异。总之,许多与菌血症相关菌种对大多数抗菌药物的耐药性已达到令人担忧的水平,且仍在上升。